SEARCH

SEARCH BY CITATION

References

  • 1
    Ginns L, Cosimi A, Morris P, eds. Transplantation. Malden: Blackwell Science; 1999.
  • 2
    Pascual M, Swinford RD, Ingelfinger JR, Williams WW, Cosimi AB, Tolkoff-Rubin N. Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today 1998; 19: 514519.
  • 3
    Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary angiographic findings. J Am Coll Cardiol 1988; 12: 334340.
  • 4
    Chaparro C, Scavuzzo M, Winton T, Keshavjee S, Kesten S. Status of lung transplant recipients surviving beyond five years. J Heart Lung Transplant 1997; 16: 511516.
  • 5
    Dallman M. Immunobiology of graft rejection. In: Ginns L, Cosimi A, Morris P, eds. Transplantation. Malden: Blackwell Science; 1999. pp. 2342.
  • 6
    Kageyama Y, Li XK, Suzuki S et al. Apoptosis is involved in acute cardiac allograft rejection in rats. Ann Thorac Surg 1998; 65: 16041609.
  • 7
    Alexander DZ, Pearson TC, Hendrix R, Ritchie SC, Larsen CP. Analysis of effector mechanisms in murine cardiac allograft rejection. Transplant Immunol 1996; 4: 4648.
  • 8
    Yamazaki S, Isobe M, Suzuki J et al. Role of selectin-dependent adhesion in cardiac allograft rejection. J Heart Lung Transplant 1998; 17: 10071016.
  • 9
    Mulligan MS, McDuffie JE, Shanley TP et al. Role of RANTES in experimental cardiac allograft rejection. Exp Mol Pathol 2000; 69: 167174.
  • 10
    Schulze A, Downward J. Navigating gene expression using microarrays – a technology review. Nat Cell Biol 2001; 3: E190E195.
  • 11
    Harkin DP. Uncovering functionally relevant signalling pathways using microarray-based expression profiling. Oncologist 2000; 5: 501507.
  • 12
    Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma and normal tissue examined by oligonucleotide arrays. Cancer Res 2001; 61: 31243130.
  • 13
    Saiura A, Mataki C, Murakami T et al. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 2001; 72: 320329.
  • 14
    Akalin E, Hendrix RC, Polavarapu G et al. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation 2001; 72: 948953.
  • 15
    Ono K, Lindsey E. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225229.
  • 16
    Searle S, Casella G, McCulloch C, eds. Variance Components. New York: John Wiley & Sons, 1992.
  • 17
    Pascoe MD, Marshall SE, Welsh KI, Fulton LM, Hughes DA. Increased accuracy of renal allograft rejection diagnosis using combined perforin, granzyme B and Fas ligand fine-needle aspiration immunocytology. Transplantation 2000; 69: 25472553.
  • 18
    Segerer S, Cui Y, Eitner F et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518531.
  • 19
    Xu XY, Honjo K, Devore-Carter D, Bucy RP. Immunosuppression by inhibition of cellular adhesion mediated by leukocyte function-associated antigen-1/intercellular adhesion molecule-1 in murine cardiac transplantation. Transplantation 1997; 63: 876885.
  • 20
    Coito AJ, Korom S, Graser E, Volk HD, Van De Water L, Kupiec-Weglinski JW. Blockage of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression. Transplantation 1998; 65: 699706.
  • 21
    Shirwan H, Barwari L, Khan NS. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides. Transplantation 1998; 66: 18021809.
  • 22
    Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 1990; 346: 281284.
  • 23
    Fischer JW, Kinsella MG, Levkau B, Clowes AW, Wight TN. Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arterioscler Thromb Vasc Biol 2000; 21: 777784.
  • 24
    Johnston IG, Paladino T, Gurd JW, Brown IR. Molecular cloning of SC1: a putative brain ECM glycoprotein show in partial similarity to osteonectin/BM40/SPARC. Neuron 1990; 4: 165176.
  • 25
    Mothe AJ, Brown IR. Selective transport of SC1 mRNA, encoding a putative ECM glycoprotein, during postnatal development of the rat cerebellum and retina. Mol Brain Res 2000; 76: 7384.